- Introduction to Clinical Research Training
- Medical Education
- United Kingdom Clinical Scholars Research Training
- Vanderbilt Hall
- Financial Aid
- Office of the Registrar
- Campus Planning and Facilities
- Ombuds Office
- Committee on Microbiological Safety
- Human Resources
- HMS Foundation Funds
- Office for Academic and Clinical Affairs
- Joint Committee on the Status of Women
- The Academy
- Global Health Research Core
- Global Clinical Scholars Research Training Program
- HMA Standing Committee on Animals
- Office of Research Compliance
- Global & Community Health
- Harvard Medical School Event Calendar
- Contact @HMS
- Office of Diversity RIA Program
- The Dean's Perspective
- Department of Pathology
- Harvard Mahoney Neuroscience Institute
- OHRA Home
- Office of Research Subject Protection
- Tools and Technology
- Alumni Association
- Cancer Biology & Therapeutics Program
- Celiac Program
- Department of Medicine
- HMS Community Values Initiative
- HMS Information Technology
- HMS TransMed Program
- Introduction to the Practice of American Medicine
- Office of Communications & External Relations
- Office of Global Education
- Shenzhen-HMS Initiative in International Education
- South American Clinical Research Training
- test page
- Safety Quality and Informatics Leadership
- Human Resources
- Jobs @ HMS
- Contact us
- Dental Medicine
- Harvard University
Thank your for participating in the 2015 election.
Newly elected council members include
Lisa Petri Henske, MD ’85
Phillip Landrigan, MD ’67
Councilor: Second Pentad (Classes of 2005–2009):
Tami Tiamfook-Morgan, MD ’04
Councilor: Fifth Pentad (Classes of 1990–1994):
Louise Aronson, MD ’92
Councilor: Ninth Pentad (Classes of 1970–1974):
James Doroshow, MD ’73
Lisa Petri Henske, MD ’85
Director, Center for LAM Research and Clinical Care, Brigham and Women's Hospital
Elizabeth (Lisa) Petri Henske is the Founding Director of the Center for LAM Research and Clinical Care at the Brigham and Women's Hospital and the Co-Director of the Brigham Research Institute. She is also a Professor of Medicine at Harvard Medical School, an Associate Member of the Broad Institute of MIT and Harvard, and a practicing medical oncologist at the Dana-Farber Cancer Institute.
The genetic cause of lymphangioleiomyomatosis (LAM) – somatic mutations in the tuberous sclerosis complex (TSC) genes – was discovered by Dr. Henske’s laboratory. She also discovered the physical interaction between the TSC1 and TSC2 proteins, which is the mechanistic underpinning of many subsequent advances in this field. Currently, her research is focused on the cellular and metabolic mechanisms underlying the pathogenesis of LAM and TSC. She has published more than 100 manuscripts on TSC and LAM. She is the Principal Investigator of the Sirolimus and Autophagy Inhibition in LAM (SAIL) clinical trial.
Outside of Boston, Dr. Henske is a member and past Chair of NIH study sections and serves on the Scientific Advisory Board of foundations that support TSC and LAM research. She is a member of the American Society for Clinical Investigation, the Association of American Physicians, and the Interurban Clinical Club. She has received awards for her research from the Tuberous Sclerosis Alliance, the LAM Foundation, and the Society for Women's Health Research (the Medtronic Prize).
Dr. Henske earned her undergraduate degree summa cum laude from Yale, where she majored in Molecular Biophysics and Biochemistry. She trained in Internal Medicine and Hematology/Oncology at the Massachusetts General Hospital, and then rose to the level of Assistant Professor at the Brigham and Women’s Hospital before moving to Fox Chase Cancer Center in Philadelphia.
Since 2008, when Dr. Henske moved back to Boston, she has been active in several spheres at HMS, including the Alumni Council, the Faculty Council, the Warren Alpert Prize Selection Committee, the MD-PhD Admissions Committee, and the Reunion Committee. She particularly enjoys interacting directly with students as a lecturer in HMS courses, an advisor to students in the Health Sciences and Technology (HST) program, and a research mentor for the Scholarly Projects program.
Dr. Henske lives in Cambridge MA with her husband Rob, who attended Harvard Business School. The Henske’s have three children. Dr. Henske grew up in Washington, D.C. and McLean, Virginia, where she was fortunate to have high school research opportunities at the National Institutes of Health. Her sister Michelle A. Petri and brother William A. Petri Jr. are also academic physicians. Dr. Henske enjoys running and plays the flute in a local orchestra.
What an incredible honor to be nominated for President! Since moving back to Boston six years ago, I’ve had the privilege of working with HMS at several different levels – through the Faculty Council and Alumni Council, the MD-PhD Admissions Committee, a course lecturer, advisor to HST students, and research mentor.
Working directly with HMS students is a consistent pleasure. They are curious, creative, endlessly optimistic about the future, and incredibly smart. They ask the hardest questions in science, medicine, and health policy. They wonder how their lives and careers will unfold, both in and out of medicine. As alumni we share so much with them – including the passion for improving lives through inquiry and research.
My objectives as President will reflect three fundamental questions:
What can the Alumni Council offer to HMS students? Current students are deeply interested in our perspectives on career paths (which rarely unfold according to plan) and family/work/life balance. As a practicing medical oncologist with a research laboratory, the Principal Investigator of a clinical trial, a parent, and spouse, I am acutely aware of this elusive “balance” - as are most alumni. Building stronger bonds between alumni and students will allow our insights in building careers and lives to be shared.
How can the Alumni Council support current and future alumni? We must continue to build connectivity between HMS and alumni, regardless of geography, and allow the deep intellectual and educational resources of the medical school to be enjoyed by more of us.
How can the Alumni Council support Harvard Medical School? Together, let us identify high-impact areas where we can advocate for the mission of HMS and strengthen our individual connections with this remarkable institution.
In conclusion, I would be privileged to serve as President of the HMS Alumni Council and will work on all three fronts to advance the role of Alumni at HMS.
Phillip Landrigan, MD ’67
Dean for Global Health, Mount Sinai School of Medicine
Dr. Philip Landrigan is a pediatrician and epidemiologist. He graduated from Boston College (1963), Harvard Medical School (1967) and the London School of Tropical Medicine & Hygiene, University of London (1977). He completed a residency in pediatrics at Children’s Hospital Boston. He trained in epidemiology at the Centers for Disease Control and Prevention and served for 15 years as a CDC epidemiologist with extended overseas tours in Nigeria and El Salvador. He has been a member of the faculty of the Icahn School of Medicine at Mount Sinai since 1985. He was elected to the Institute of Medicine in 1987.
Dr. Landrigan’s pioneering studies showing that lead is toxic to children at even very low levels was critical in persuading the US government to remove lead from gasoline and paint – actions that have reduced incidence of lead poisoning by 95%, raised the intelligence of a generation of American children and saved this country $200 billion each year.
Dr. Landrigan chaired a committee at the National Academy of Sciences which found that children are uniquely vulnerable to pesticides and other toxic chemicals. This work provided the foundation for the Food Quality Protection Act, the federal law on pesticides, the only US environmental statute containing explicit provisions to protect the health of children. He was a leader in creating the National Children’s Study.
From 1995 to 1997, Dr. Landrigan served on the Presidential Advisory Committee on Gulf War Veteran's Illnesses. In 1997-1998, he served as Senior Advisor on Children's Health to the Administrator of the U.S. Environmental Protection Agency and was instrumental in helping to establish a new Office of Children's Health Protection at EPA.
Dr. Landrigan served from 1996 to 2005 in the Medical Corps of the United States Naval Reserve. He retired in 2005 at the rank of Captain. He served in Korea and Ghana and was Officer-in-Charge of the West Africa Training Cruise, a medical humanitarian mission to Senegal in 2004 that saw over 11,000 patients. He was awarded the Navy Commendation Medal (3 awards), the National Defense Service Medal and the Secretary of Defense Medal for Outstanding Public Service. He continues to serve as Surgeon General of the New York Naval Militia, the maritime component of New York's National Guard.
In New York, Dr. Landrigan has directed medical and epidemiological studies of the rescue workers who responded to the attacks on the World Trade Center on September 11, 2001.
I am honored to be nominated to be Treasurer of the HMS Alumni Council. If elected, I will try to return some of the many gifts I have been given by HMS by working with Dean Flier, school leadership and fellow alumni/ae to build a national and international network of mentors who can guide our students and graduates throughout their careers.
I am a pediatrician, epidemiologist and occupational/environmental physician. I have worked in government, in academia and with the World Health Organization. I would bring to the Alumni Council the lessons learned from nearly five decades spent in public health, preventive medicine, occupational medicine, children's environmental health and global health.
Evidence-based advocacy is my passion. I take great satisfaction in using epidemiology to discover threats to health and then in building broad and sometimes eclectic coalitions who can speak truth to power and translate scientific findings into actions that improve the health of the public. Being a part of the teams that successfully removed lead from gasoline, controlled exposures to benzene in the workplace, reformed US federal pesticide law and documented the need to provide health benefits for the 9/11 first responders have been highlights of my professional life.
Mentoring students is my second joy. I love working with students, especially those with interests in public health and community medicine who have come to understand that every patient comes from a culture, a place and a population and who recognize that the care of the patient requires knowing the community.
My wife Mary and are blessed with 3 children and 7 grandchildren, all of whom live in greater Boston. We are enormously proud that our two medical children are both HMS faculty - Christopher in the Department of Medicine at Boston Children's Hospital and Mary Frances in the Department of Anesthesiology, also at Children's.
Tami Tiamfook-Morgan, MD ’04
Ellicott City, MD
Attending Emergency Physician, Emergency Medicine Associates, Carroll Hospital Center
Dr. Tami Tiamfook-Morgan, was born and raised in Brooklyn, NY. Despite living in an inner city neighborhood where she could have easily succumb to the negative images and distractions that surrounded her, she always saw positivity in potential. Potential in her community, potential in her peers, and most importantly potential in herself. She used that perspective to drive her down a focused path. Tami took an accelerated course load and finished High School in three years, graduating at just 16 years old. She continued with that drive in college and ultimately graduated from Cornell University with a Bachelors in Science cum laude. She then pursued her interest in medicine at Harvard Medical School where she graduated in 2004 with honors.
Throughout the way, Tami always emerged herself in her community to guide the potential of others as well. An example of this came during medical school when she founded a group, called “Just for Girls”. Tami chose an underserved neighborhood in Roxbury to start a program where she matched up inner city girls, with mentors in medicine. This resulted in an open environment where the girls felt comfortable enough to share the things concerning them in school and life in general, and provided the mentors with great opportunities for meaningful guidance.
After medical school, Tami went on to continue her residency at Harvard Affiliated Emergency Medicine residency at Massachusetts General Hospital and Brigham and Women’s Hospital. Here, Tami focused on researching pre-hospital care and primarily pre hospital airway management safety. After completing residency, she took a job as an emergency medicine attending at Mount Auburn hospital in Cambridge, MA. This hospital is the community teaching hospital of Harvard Medical School. Tami continued to be involved in medical education as she was the residency coordinator for residents as they rotated at that site. She performed monthly performance evaluations and gave lectures throughout the year. She also lectured the internal medicine residents at Mount Auburn on different emergency medicine topics and assisted in medical student procedural courses at HMS. She also taught Pediatric Advanced Life Support (PALS) and Advanced Cardiac Life Support (ACLS) classes throughout Boston.
Last year, Tami moved from New England to Maryland to support her husband’s business career. Although it was difficult to leave their home of 13 years, they were excited about the change and new opportunities. Tami currently works at a large community hospital in Maryland which serves a wide region and diverse range of patients. She currently serves on the Medical Staff Quality Committee which is responsible for defining, prioritizing, overseeing and monitoring the hospitals performance improvement activities.
Throughout her career, Tami has always found time for family. She is the proud mother of four kids, Dwane Jr. – 6, David – 5, Daniel – 3, and Mia – 1. She has also been the legal guardian of her youngest sister Jasmine – 14, for the past 5 years as a way to help her on a path to success that started in a similar Brooklyn setting.
I am honored to be nominated to the HMS alumni council. HMS is not only where I received my medical degree, it brought me to a city and a setting that developed me into the doctor that I am today. I look forward to serving as a liaison so I can help give back to the organization that has given me so much.
The best way for any organization to continue to move forward is to continuously evolve for the better. To do that, you have to understand where the community is going as well as any issues that key constituents are currently facing. I look forward to helping facilitate those conversations. Understanding the needs and concerns of both students and the university to create a successful forward path will be an exciting challenge. I look forward to the opportunity to reengage with students and my alumni peers in a way to continue to drive forward the organization that has given so much to me.
Louise Aronson, MD ’92
San Francisco, CA
Professor, University of California, San Francisco
Louise Aronson is a geriatrician, educator, and writer. A Professor of Medicine at the University of California San Francisco (UCSF), she currently serves as Chief of Geriatrics Education and Director of the Optimizing Aging Center and UCSF Medical Humanities. Her clinical practice includes home-based primary, hospital and palliative care for older adults through the Care at Home program. She writes about medicine, aging, health care, and public medical communication for medical journals and the lay press and is the author of A History of the Present Illness.
A native San Franciscan, Louise received her BA magna cum laude in history and anthropology at Brown University. While working with refugees in the US and on the Thai-Cambodian border, she realized that medicine would provide her with both a varied and interesting career and the skills and opportunities to make a difference for vulnerable populations. She received her medical degree from Harvard Medical School in 1992 and completed an internal medicine residency, primary care chief residency, and geriatrics fellowship at UCSF. After training, Louise initially joined the UCSF faculty, founding the Housecalls program, the institution’s first geriatrics clinical rotations, and serving as the Medical Director of UCSF Home Care. She then moved to the community to hone her clinical skills across care settings and pursue a Master’s of Fine Arts degree in creative writing.
In 2006, Louise returned to the UCSF faculty where she has served as Director of the Pathways to Discovery Program and the Northern California Geriatrics Education center, editor of the JGIM Healing Arts section, and associate editor for the JAMA Care of the Aging Patient series. Louise’s research and scholarship focus on geriatrics education, reflective learning, and public medical writing and communication. She is particularly interested in training current and future health professionals to provide optimal care to older adults and the use of writing to harness the unique expertise and experiences of clinicians and medical scientists in service of health and health care. A former Teaching Scholar, Geriatrics Faculty Scholar, and Medical Education Research Fellow, Louise has received the California Homecare Physician of the Year award, a Geriatric Academic Career Award, the Cooke Award for the Scholarship of Teaching and Learning, UCSF mentorship and teaching awards, the Lieberman Scholar Award, the AOA Edward D. Harris Professionalism Award, an Arnold P. Gold Professorship for Humanism in Medicine, and the American Geriatrics Society Clinician-Educator of the Year award.
Louise’s writing has appeared in the Lancet, the New England Journal, JAMA, Health Affairs, the New York Times, Narrative Magazine, the Bellevue Literary Review, and the San Francisco Chronicle, among other publications. She has won the Sonora Review Prize, the New Millennium Short Fiction Award, and three Pushcart nominations for her short fiction. A History of the Present Illness was a finalist for the Chautauqua Prize and the PEN American award for best debut fiction.
I am excited to be considered for a position on the Alumni Council for the very same reasons I was excited to attend HMS: the opportunity to collaborate with smart, dedicated, innovative people on work that matters. I still vividly recall telephoning one of my interviewers from New York’s Penn Station (a process that involved using a large box attached to a wall into which I inserted coins) to say I’d loved HMS but had never seen myself as one of “those people.” He laughed and gave me some of the best advice I’ve ever received: You won’t find a more impressive group; “those people” are the ones from whom you’ll learn what you need to know to be a good doctor. He was absolutely right.
Yet in recent years, I have begun to wonder what being a good doctor means in the twenty first century. The digital revolution has fundamentally and irrevocably changed the way we learn, communicate, and practice. Equally important, for over a decade health care has been at the center of local and national political debates and the subject of daily news stories detailing high costs and errors, systemic inequalities, and unprecedented rates of patient dissatisfaction and physician burnout. But with changes and challenges come opportunities, and I can think of no school as well positioned to creatively and effectively tackle these challenges as HMS.
If elected to the Alumni Council, I would work with Dean Flier and my colleagues to consider questions including: How can we produce physicians eager to meet society’s most pressing health care needs? How do we create doctors who are both high tech and high touch? And how do we inspire and sustain a health care workforce with the skills and aspirations to inform not only care and research but also to lead in health policy, public education, quality and safety?
James Doroshow, MD ’73
Deputy Director, National Cancer Institute; National Institutes of Health
Jim Doroshow received his A.B. degree from Harvard College in 1969 and graduated from Harvard Medical School in 1973. Following a residency in medicine at the Massachusetts General Hospital (1973 to 1975), he completed a fellowship in Medical Oncology at the Medicine and Clinical Pharmacology Branches of the National Cancer Institute, NIH. Dr. Doroshow has been the Deputy Director for Clinical and Translational Research of the National Cancer Institute since 2011, and the Director of NCI’s Division of Cancer Treatment and Diagnosis since 2004. He continues to pursue his own research program which is devoted to the discovery of new, molecularly-targeted anticancer agents as a tenured Senior Investigator in the Developmental Therapeutics Branch of the NCI’s intramural Center for Cancer Research.
From 1983 to 2004, Dr. Doroshow was the Chairman of the City of Hope Comprehensive Cancer Center’s Department of Medical Oncology and Therapeutics Research, and Associate Cancer Center Director for Clinical Investigation. In those capacities, he established and directed the City of Hope’s NCI-funded early therapeutics program, its membership in a national clinical trials network supported by the NCI (Southwest Oncology Group), and an NCI-funded training program to develop physician-investigators in the early stages of their academic careers. From the time of his first research grant in 1980, Dr. Doroshow was continuously funded by the NCI until he moved to the NIH in 2004. He is the author of over 400 full-length publications in the areas of cancer molecular pharmacology, the role of oxidant stress in tumor cell signal transduction, and novel therapeutic approaches to solid tumors.
Dr. Doroshow served from 1990-1992 as Chairman of the National Institutes of Health Experimental Therapeutics II Study Section, from 1995-2001 as a member of the Subspecialty Board on Medical Oncology of the American Board of Internal Medicine, from 1999-2000 as Chairman of NCI’s Scientific Review Group A-Cancer Centers, and from 2004-2007 as a member of the FDA’s Oncologic Drugs Advisory Committee. Dr. Doroshow chaired the NCI’s Clinical Trials Working Group from 2004-2005 that developed a comprehensive set of initiatives to restructure the national cancer clinical trials enterprise which was successfully finalized in 2014; and the NCI’s Operational Efficiency Working Group from 2008-2010 that developed standards to significantly shorten the timeline for cancer clinical trial implementation across all of NCI’s clinical trials platforms. From 2012-2013 he served as the chair of the NIH Clinical Trials Working Group which made a series of recommendations that are now being implemented to improve the overall clinical research effort of the NIH. He is currently a member of both the Forum on Drug Discovery, Development, and Translation as well as the National Cancer Policy Forum of the Institute of Medicine of the National Academies of Science, and the Associate Editor for Oncology of the 25th Edition of the Cecil Textbook of Medicine.
Like so many classmates, my four year stay at HMS was the defining period of my personal and professional life. I was extraordinarily fortunate to meet my future wife (Robin Winkler, HMS ’73) and to be mentored by an exceptional oncologist and clinician investigator (Donald Kaufman, M.D.) who shaped my future academic career. I think it highly likely that those two events played a critical role in foreshadowing our daughter Deborah’s own experience at HMS (class of 2013). Having engaged the curriculum and the classmates of two eras (in person and as a father), I remain in awe of the range of excellence—scientific, medical, and personal—that is a central feature of the medical school.
Since so much of my time is now devoted to the impossible task of trying to make a shrinking pot of federal research money go further, I constantly wonder how/why bright students choose--against the odds--to consider academic careers. Robin and I worry what the world of academic medicine will be like for our daughter, and how changes in generational priorities will affect the availability of medical care in what seems like the very near term. A reasonable supposition, however, is that current and future HMS classes, like previous generations, will adapt--and probably quite well. Without evidence, I can only imagine that physicians of these new generations will be buoyed by the exciting opportunities available to them--based on remarkable new science, unimaginable (to us in 1973) computational and bioinformatic technologies, and vastly different interpersonal professional (team) relationships that will form the basis of the way they practice--without being hindered by trying to reproduce the past.
I would be most grateful if there is any way that I could assist the Alumni Council in continuing to advance the broad range of achievement that makes HMS unique.
The Council is composed of 15 members, representing alumni by pentads, elected to a three-year term and meeting three times annually. The Council serves a consultative and advisory role to the Dean of the Faculty of Medicine at Harvard Medical School by listening and responding to current issues. It also appoints, in consultation with the Dean, the Chair of Alumni Relations and the Chair of the Alumni Fund.
2016 Alumni Council
Those elected would "take office" for a three year term and are expected to attend three, all-day meetings in Boston each year and possess a willingness to listen to fellow alumni and bring their interests and concerns to the Alumni Council. If you would like to recommend an HMS alumna or alumnus (including yourself), please send your nomination via email to firstname.lastname@example.org.